These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 28426111)

  • 61. Quality improvement in travel medicine: a programme for yellow fever vaccination centres in England, Wales and Northern Ireland.
    Boddington NL; Simons H; Launders N; Hill DR
    Qual Prim Care; 2011; 19(6):391-8. PubMed ID: 22340901
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Yellow fever vaccination: update on rare and severe adverse effects].
    Receveur MC; Bruyand M; Pistone T; Malvy D
    Med Mal Infect; 2009 Apr; 39(4):234-41. PubMed ID: 19167852
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Fractional-dose yellow fever vaccination: how much more can we do with less?
    Visser LG
    Curr Opin Infect Dis; 2019 Oct; 32(5):390-393. PubMed ID: 31335440
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Linking yellow fever vaccinator approval and renewal with training in travel medicine in New Zealand.
    O'Brien B; Leggat PA
    Travel Med Infect Dis; 2010 Jul; 8(4):210-2. PubMed ID: 20970723
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Prevention of yellow fever in travellers: an update.
    Reno E; Quan NG; Franco-Paredes C; Chastain DB; Chauhan L; Rodriguez-Morales AJ; Henao-Martínez AF
    Lancet Infect Dis; 2020 Jun; 20(6):e129-e137. PubMed ID: 32386609
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Notes from the Field: Investigation of Patients Testing Positive for Yellow Fever Viral RNA After Vaccination During a Mass Yellow Fever Vaccination Campaign - Angola, 2016.
    Boyd AT; Dombaxe D; Moreira R; Oliveira MS; Manuel E; Colorado CN; Lanzieri TM
    MMWR Morb Mortal Wkly Rep; 2017 Mar; 66(10):282-283. PubMed ID: 28301446
    [No Abstract]   [Full Text] [Related]  

  • 67. Fears rise over yellow fever's next move.
    Butler D
    Nature; 2016 Apr; 532(7598):155-6. PubMed ID: 27075072
    [No Abstract]   [Full Text] [Related]  

  • 68. Access to yellow fever travel vaccination centres in England, Wales, and Northern Ireland: A geographical study.
    Petersen J; Simons H; Patel D
    Travel Med Infect Dis; 2017; 18():24-29. PubMed ID: 28698027
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Safety of the yellow Fever vaccine: a retrospective study.
    Nordin JD; Parker ED; Vazquez-Benitez G; Kharbanda EO; Naleway A; Marcy SM; Molitor B; Kuckler L; Baggs J
    J Travel Med; 2013; 20(6):368-73. PubMed ID: 24118538
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Update: Temporary Total Depletion of U.S. Licensed Yellow Fever Vaccine for Civilian Travelers Addressed by Investigational New Drug Use of Imported Stamaril Vaccine.
    Gershman MD; Sotir MJ
    MMWR Morb Mortal Wkly Rep; 2017 Jul; 66(29):780. PubMed ID: 28749924
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Prescription of Yellow Fever Vaccine: The Experience of the International Vaccination Centre of the Loures-Odivelas Health Centre Group].
    Martinho C; Lopes D; Bastos L; Esteves H
    Acta Med Port; 2018 Dec; 31(12):724-729. PubMed ID: 30684369
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The response to re-emergence of yellow fever in Nigeria, 2017.
    Nwachukwu WE; Yusuff H; Nwangwu U; Okon A; Ogunniyi A; Imuetinyan-Clement J; Besong M; Ayo-Ajayi P; Nikau J; Baba A; Dogunro F; Akintunde B; Oguntoye M; Kamaldeen K; Fakayode O; Oyebanji O; Emelife O; Oteri J; Aruna O; Ilori E; Ojo O; Mba N; Nguku P; Ihekweazu C
    Int J Infect Dis; 2020 Mar; 92():189-196. PubMed ID: 31935537
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Revised recommendations for yellow fever vaccination for international travellers, 2011.
    Wkly Epidemiol Rec; 2011 Sep; 86(37):401-11. PubMed ID: 21969938
    [No Abstract]   [Full Text] [Related]  

  • 74. The global burden of yellow fever.
    Gaythorpe KA; Hamlet A; Jean K; Garkauskas Ramos D; Cibrelus L; Garske T; Ferguson N
    Elife; 2021 Mar; 10():. PubMed ID: 33722340
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Tolerance and humoral immune response to the yellow fever vaccine in sickle cell disease children treated with hydroxyurea: a multicentre prospective study.
    Koehl B; Aupiais C; Schinckel N; Mornand P; Odièvre MH; Niakate A; Brousse V; Ithier G; Missud F; Holvoet L; Benkerrou M; Sorge F; Faye A
    J Travel Med; 2021 Apr; 28(3):. PubMed ID: 33550421
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Yellow fever and Hajj: with all eyes on Zika, a familiar flavivirus remains a threat.
    Ahmed QA; Memish ZA
    Front Med; 2016 Dec; 10(4):527-530. PubMed ID: 27757795
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever.
    Jentes ES; Poumerol G; Gershman MD; Hill DR; Lemarchand J; Lewis RF; Staples JE; Tomori O; Wilder-Smith A; Monath TP;
    Lancet Infect Dis; 2011 Aug; 11(8):622-32. PubMed ID: 21798462
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [The risk of yellow fever in travellers].
    Roukens AH; Visser LG
    Ned Tijdschr Geneeskd; 2006 Aug; 150(33):1815-20. PubMed ID: 16967591
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Shortage of yellow fever vaccination: A travel medicine emergency for Chilean travellers.
    Weitzel T; Vial P; Perret C; Aguilera X
    Travel Med Infect Dis; 2019; 28():1-2. PubMed ID: 30708130
    [No Abstract]   [Full Text] [Related]  

  • 80. Safety and immunogenicity of typhoid fever and yellow fever vaccines when administered concomitantly with quadrivalent meningococcal ACWY glycoconjugate vaccine in healthy adults.
    Alberer M; Burchard G; Jelinek T; Reisinger E; Beran J; Hlavata LC; Forleo-Neto E; Dagnew AF; Arora AK
    J Travel Med; 2015; 22(1):48-56. PubMed ID: 25308927
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.